The European Consortium for Communicating Gene and Cell Therapy Information (EuroGCT) has two major objectives: • To provide patients, people affected by conditions, healthcare professionals and citizens with accurate scientific, legal, ethical and societal information and with engagement opportunities, and thus to support better informed decision-making related to cell and gene-based therapies. • To facilitate better decision-making at key points in development of new therapies and thus enable improved product development, by providing the research community and regulatory and healthcare authorities with an information source on the practical steps needed for cell and gene therapy development. Work Package 4 (WP4) is developing an information hub for the research and regulatory communities that facilitates access of these communities to information on the practical steps needed for cell- and gene-based therapy development and promotes information exchange within and between these communities. Deliverable 4.2 is a set of information resources on the practical steps needed for cell and gene therapy development, which can be viewed online at www.eurogct.org/researchpathways.